Chapter 1. Preface
1.1. Report Scope and Description
1.2. Research Methodology
1.2.1. Phase I-Secondary Research
1.2.2. Phase II-Primary Research
1.2.3. Phase III-Expert Panel Review
1.2.4. Assumptions
1.2.5. Approach Adopted
Chapter 2. Executive Summary
2.1. Americas and Europe Chagas Disease Drugs Market Portraiture
2.1.1. Americas and Europe Chagas Disease Drugs Market, by Drug Type, 2016
2.1.2. Americas and Europe Chagas Disease Drugs Market, by Geography, 2016
Chapter 3. Chagas Disease Drugs: Market Dynamics and Outlook
3.1. Market Definition and Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.5. Attractive Investment Proposition, by Geography
3.6. Competitive Landscape
3.6.1. Competitive Landscape, by Key Players, 2016
3.7. Top 3 Countries in Americas and Europe Chagas Disease Drugs Market, 2016
Chapter 4. Americas and Europe Chagas Disease Drugs Market, by Drug Type, 2015 – 2025 (US$ Mn)
4.1. Overview
4.2. Benznidazole
4.3. Nifurtimox
4.4. Others
Chapter 5. Americas and Europe Chagas Disease Drugs Market, by Geography, 2015 – 2025
5.1. Overview
5.2. North America Chagas Disease Drugs Market Analysis, 2015 – 2025
5.2.1. North America Chagas Disease Drugs Market, by Drug Type, 2015 – 2025 (US$ Mn)
5.2.2. North America Chagas Disease Drugs Market, by Country, 2015 – 2025 (US$ Mn)
5.2.2.1. United States
5.2.2.2. Canada
5.3. Europe Chagas Disease Drugs Market Analysis, 2015 – 2025
5.3.1. Europe Chagas Disease Drugs Market, by Drug Type, 2015 – 2025 (US$ Mn)
5.3.2. Europe Chagas Disease Drugs Market, by Country, 2015 – 2025 (US$ Mn)
5.3.2.1. United Kingdom
5.3.2.2. Spain
5.3.2.3. France
5.3.2.4. Rest of Europe
5.4. Latin America Chagas Disease Drugs Market Analysis , 2015 – 2025
5.4.1. Latin America Chagas Disease Drugs Market, by Drug Type, 2015 – 2025 (US$ Mn)
5.4.2. Latin America Chagas Disease Drugs Market, by Country, 2015 – 2025 (US$ Mn)
5.4.2.1. Argentina
5.4.2.2. Brazil
5.4.2.3. Mexico
5.4.2.4. Rest of Latin America
Chapter 6. Company Profiles
6.1. Bayer AG
6.1.1. Business Description
6.1.2. Financial Information (Subject to data availability)
6.1.3. Drug Type Portfolio
6.1.4. Key Developments
6.2. F. Hoffmann-La Roche Ltd.
6.3. Humanigen, Inc.
6.4. Johnson & Johnson
6.5. KaloBios Pharmaceuticals, Inc.
6.6. Savant Neglected Diseases, LLC.
List of Figures
FIG. 1 Chagas Disease Drugs: Market Methodology
FIG. 2 Americas and Europe Chagas Disease Drugs Market, by Drug Type, 2016 (US$ Mn)
FIG. 3 Americas and Europe Chagas Disease Drugs Market, by Geography, 2016 (Value %)
FIG. 4 Attractive Investment Proposition: Americas and Europe Chagas Disease Drugs Market, by Geography, 2016
FIG. 5 Market Competition Landscape, by Key Players, 2016
FIG. 6 Americas and Europe Benznidazole Market, 2015 – 2025 (US$ Mn)
FIG. 7 Americas and Europe Nifurtimox Market, 2015 – 2025 (US$ Mn)
FIG. 8 Americas and Europe Other Chagas Dieses Market, 2015 – 2025 (US$ Mn)
FIG. 9 United States Chagas Disease Drugs Market, 2015 – 2025 (US$ Mn)
FIG. 10 Canada Chagas Disease Drugs Market, 2015 – 2025 (US$ Mn)
FIG. 11 United Kingdom Chagas Disease Drugs Market, 2015 – 2025 (US$ Mn)
FIG. 12 Spain Chagas Disease Drugs Market, 2015 – 2025 (US$ Mn)
FIG. 13 France Chagas Disease Drugs Market, 2015 – 2025 (US$ Mn)
FIG. 14 Rest of Europe Chagas Disease Drugs Market, 2015 – 2025 (US$ Mn)
FIG. 15 Argentina Chagas Disease Drugs Market, 2015 – 2025 (US$ Mn)
FIG. 16 Brazil Chagas Disease Drugs Market, 2015 – 2025 (US$ Mn)
FIG. 17 Mexico Chagas Disease Drugs Market, 2015 – 2025 (US$ Mn)
FIG. 18 Rest of Latin America Chagas Disease Drugs Market, 2015 – 2025 (US$ Mn)
List of Tables
TABLE 1 Market Positioning of Key Players in Americas and Europe Chagas Disease Drugs Market
TABLE 2 Top 3 Countries in Americas and Europe Chagas Disease Drugs Market
TABLE 3 Americas and Europe Chagas Disease Drugs Market, by Drug Type, 2015 – 2025 (US$ Mn)
TABLE 4 America and Europe Chagas Disease Drugs Market, by Geography, 2015 – 2025 (US$ Mn)
TABLE 5 North America Chagas Disease Drugs Market, by Drug Type, 2015 – 2025 (US$ Mn)
TABLE 6 North America Chagas Disease Drugs Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 7 Europe Chagas Disease Drugs Market, by Drug Type, 2015 – 2025 (US$ Mn)
TABLE 8 Europe Chagas Disease Drugs Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 9 Latin America Chagas Disease Drugs Market, by Drug Type, 2015 – 2025 (US$ Mn)
TABLE 10 Latin America Chagas Disease Drugs Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 11 Bayer AG.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 12 F. Hoffmann-La Roche Ltd.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 13 Humanigen, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 14 Johnson & Johnson: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 15 KaloBios Pharmaceuticals, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 16 Savant Neglected Diseases, LLC.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)